Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 4
1991 2
1992 3
1993 1
1994 5
1995 5
1996 4
1997 8
1998 7
1999 6
2000 10
2001 9
2002 14
2003 14
2004 14
2005 11
2006 14
2007 15
2008 15
2009 16
2010 14
2011 31
2012 24
2013 21
2014 22
2015 26
2016 19
2017 32
2018 28
2019 22
2020 38
2021 31
2022 30
2023 25
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Results by year

Filters applied: . Clear all
Page 1
Overview of Castleman disease.
Dispenzieri A, Fajgenbaum DC. Dispenzieri A, et al. Blood. 2020 Apr 16;135(16):1353-1364. doi: 10.1182/blood.2019000931. Blood. 2020. PMID: 32106302 Free article. Review.
Castleman disease (CD) describes a group of at least 4 disorders that share a spectrum of characteristic histopathological features but have a wide range of etiologies, presentations, treatments, and outcomes. ...Anti-interleukin-6-directed therapies are highly effe
Castleman disease (CD) describes a group of at least 4 disorders that share a spectrum of characteristic histopathological fea
Castleman disease.
Carbone A, Borok M, Damania B, Gloghini A, Polizzotto MN, Jayanthan RK, Fajgenbaum DC, Bower M. Carbone A, et al. Nat Rev Dis Primers. 2021 Nov 25;7(1):84. doi: 10.1038/s41572-021-00317-7. Nat Rev Dis Primers. 2021. PMID: 34824298 Free PMC article. Review.
Castleman disease (CD), a heterogeneous group of disorders that share morphological features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical presentation and disease course. ...
Castleman disease (CD), a heterogeneous group of disorders that share morphological features, is divided into unicentric CD an
POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A. Dispenzieri A. Am J Hematol. 2019 Jul;94(7):812-827. doi: 10.1002/ajh.25495. Epub 2019 May 23. Am J Hematol. 2019. PMID: 31012139 Free article. Review.
The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease. Minor features include organomegaly, endocrinopathy, charac …
The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular …
Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC. Liu AY, et al. Lancet Haematol. 2016 Apr;3(4):e163-75. doi: 10.1016/S2352-3026(16)00006-5. Epub 2016 Mar 17. Lancet Haematol. 2016. PMID: 27063975 Review.
Castleman Disease.
Wang W, Medeiros LJ. Wang W, et al. Surg Pathol Clin. 2019 Sep;12(3):849-863. doi: 10.1016/j.path.2019.03.003. Epub 2019 May 23. Surg Pathol Clin. 2019. PMID: 31352991 Review.
Castleman disease (CD) is divided clinically into unicentric or multicentric type. ...Therapy is required for most patients with multicentric CD, but there is no consensus approach currently. As is evidence, the designation Castleman disease encompasse
Castleman disease (CD) is divided clinically into unicentric or multicentric type. ...Therapy is required for most patients wi
Hematologic cancers in individuals infected by HIV.
Carbone A, Vaccher E, Gloghini A. Carbone A, et al. Blood. 2022 Feb 17;139(7):995-1012. doi: 10.1182/blood.2020005469. Blood. 2022. PMID: 34469512 Free article. Review.
The incidence of other lymphomas including Burkitt lymphoma, primary effusion lymphomas, and plasmablastic lymphoma of the oral cavity remain stable, whereas the incidence of Hodgkin lymphoma and Kaposi sarcoma-associated herpesvirus (KSHV)-associated multicentric Castleman
The incidence of other lymphomas including Burkitt lymphoma, primary effusion lymphomas, and plasmablastic lymphoma of the oral cavity remai …
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. van Rhee F, et al. Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4. Blood. 2018. PMID: 30181172 Free PMC article.
Castleman disease (CD) describes a group of heterogeneous hematologic disorders with characteristic histopathological features. ...An international Working Group of 42 experts from 10 countries was convened by the Castleman Disease Collaborative Networ
Castleman disease (CD) describes a group of heterogeneous hematologic disorders with characteristic histopathological features
POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management.
Dispenzieri A. Dispenzieri A. Am J Hematol. 2021 Jul 1;96(7):872-888. doi: 10.1002/ajh.26240. Epub 2021 May 31. Am J Hematol. 2021. PMID: 34000085 Free article.
The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease. Minor features include organomegaly, endocrinopathy, charac …
The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular …
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS. Fajgenbaum DC, et al. Blood. 2017 Mar 23;129(12):1646-1657. doi: 10.1182/blood-2016-10-746933. Epub 2017 Jan 13. Blood. 2017. PMID: 28087540 Free PMC article.
Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction caused by a cyt …
Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder …
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.
van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fosså A, Simpson D, Capra M, Liu T, Hsieh RK, Goh YT, Zhu J, Cho SG, Ren H, Cavet J, Bandekar R, Rothman M, Puchalski TA, Reddy M, van de Velde H, Vermeulen J, Casper C. van Rhee F, et al. Lancet Oncol. 2014 Aug;15(9):966-74. doi: 10.1016/S1470-2045(14)70319-5. Epub 2014 Jul 17. Lancet Oncol. 2014. PMID: 25042199 Clinical Trial.
493 results